Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Maitri Health Technologies expands team as COVID-19 testing demand increases

New operations and administration staff have been added to support growth

Maitri Health Technologies Corp. (CSE:MTEC), a global platform for healthcare security, has added staff in new and key project management leadership and administrative functions to meet demands from new and existing clients across North America.

The company said it expects to continue to add needed staff for laboratories and field personnel for COVID-19 screening tests over the coming months. This is a result of the increased spread of COVID-19 variants and more testing in all organizations.

READ: Maitri Health Technologies says Abbas Khan, co-founder of Bloom Health, will be chief marketing officer after acquisition

"Navigating through the Delta Variant surge is a priority with our new and existing clients," said Andrew Morton, CEO of Maitri, in a statement.

"We have an expanding opportunity to sell our health-tech platform while answering the call to support immediate needs of TV/Film Studios, Fortune 500 and education with their testing needs. Our commitment to our vision of 'Unstoppable is Possible' is supported by our labs located in key hubs the United States.”

Meanwhile, the company also announced that it has reached an agreement with an arms-length creditor pursuant to which it will settle outstanding indebtedness totaling $579,310 through the issuance of 2 million common shares at $0.27 each. The creditor has agreed that the shares will be subject to resale restrictions for 24 months following issuance.

Contact the author: patrick@proactiveinvestors.com

Follow him on Twitter @PatrickMGraham

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK